Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 247,053 | 184,052 | 153,298 | 99,119 | 86,810 |
| Marketable Securities | 157,173 | 141,838 | 125,283 | 136,069 | 133,956 |
| Receivables | 104,779 | 101,639 | 105,556 | 96,956 | 99,079 |
| Inventories | 103,438 | 96,782 | 104,353 | 96,520 | 92,130 |
| TOTAL | $632,214 | $543,113 | $509,994 | $447,255 | $429,324 |
| Non-Current Assets | |||||
| PPE Net | 168,850 | 171,804 | 173,927 | 175,783 | 180,310 |
| Investments And Advances | 0 | 36,542 | 38,459 | 0 | 0 |
| Intangibles | 617,857 | 632,179 | 646,501 | 660,823 | 675,145 |
| Other Non-Current Assets | 227,899 | 199,683 | 205,505 | 250,601 | 257,602 |
| TOTAL | $1,014,606 | $1,040,208 | $1,064,392 | $1,087,207 | $1,113,057 |
| Total Assets | $1,646,820 | $1,583,321 | $1,574,386 | $1,534,462 | $1,542,381 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 8,641 | 8,641 | 8,641 | 19,504 |
| Accounts payable and accrued liabilities | 18,730 | 8,982 | 15,698 | 16,511 | 24,206 |
| Accrued Expenses | 64,811 | 66,818 | 64,243 | 59,884 | 56,221 |
| TOTAL | $92,690 | $93,444 | $97,383 | $93,661 | $108,912 |
| Non-Current Liabilities | |||||
| Long Term Debt | 109,751 | 112,477 | 115,202 | 117,965 | 134,823 |
| Other Non-Current Liabilities | 565,101 | 485,238 | 491,671 | 491,285 | 490,671 |
| TOTAL | $674,852 | $597,715 | $606,873 | $609,250 | $625,494 |
| Total Liabilities | $767,542 | $691,159 | $704,256 | $702,911 | $734,406 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,127 | 46,546 | 46,501 | 46,438 | 46,417 |
| Common Shares | 47 | 47 | 46 | 46 | 46 |
| Retained earnings | -78,931 | -97,817 | -106,796 | -131,666 | -142,524 |
| Other shareholders' equity | -16 | 152 | 247 | -10 | -173 |
| TOTAL | $879,278 | $892,162 | $870,130 | $831,551 | $807,975 |
| Total Liabilities And Equity | $1,646,820 | $1,583,321 | $1,574,386 | $1,534,462 | $1,542,381 |